140 related articles for article (PubMed ID: 23651182)
1. Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis.
Dang LJ; Lubel JS; Gunatheesan S; Hosking P; Su J
Australas J Dermatol; 2014 Feb; 55(1):75-9. PubMed ID: 23651182
[TBL] [Abstract][Full Text] [Related]
2. [Infliximab-induced psoriasis in an adolescent with ulcerative colitis].
García Morin M; González Ruiz De León E; Tolín Hernani M; Sánchez Sánchez C
An Pediatr (Barc); 2014 Jan; 80(1):e18-9. PubMed ID: 22475462
[No Abstract] [Full Text] [Related]
3. Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease--what is the role of anti-TNF antibody?
Farkas K; Nagy F; Kovács L; Wittmann T; Molnár T
J Crohns Colitis; 2013 May; 7(4):e143-5. PubMed ID: 22818164
[TBL] [Abstract][Full Text] [Related]
4. Borreliosis mimicking lupus-like syndrome during infliximab treatment.
Molin S; Ruzicka T; Prinz JC
Clin Exp Dermatol; 2010 Aug; 35(6):631-3. PubMed ID: 20184613
[TBL] [Abstract][Full Text] [Related]
5. [Development of lupus erythematosus during infliximab therapy].
Gyöngyösi N; Lőrincz K; Kárpáti S; Wikonkál N
Orv Hetil; 2013 Apr; 154(15):590-8. PubMed ID: 23567877
[TBL] [Abstract][Full Text] [Related]
6. [A case of infliximab-related liver damage -case report and literature review].
Arai O; Omoto K; Notohara K; Shibata N; Kuboki M; Ikeda H
Nihon Shokakibyo Gakkai Zasshi; 2013 Jan; 110(1):104-11. PubMed ID: 23303236
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced hepatitis and lupus during infliximab treatment for psoriasis: case report and literature review.
Poulin Y; Thérien G
J Cutan Med Surg; 2010; 14(2):100-4. PubMed ID: 20338127
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriaisis.
Fairhurst DA; Sheehan-Dare R
Clin Exp Dermatol; 2009 Apr; 34(3):421-2. PubMed ID: 19309375
[No Abstract] [Full Text] [Related]
9. Drug induced autoimmune hepatitis and TNF-α blocking agents: is there a real relationship?
Efe C
Autoimmun Rev; 2013 Jan; 12(3):337-9. PubMed ID: 22841985
[TBL] [Abstract][Full Text] [Related]
10. Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis.
Marques M; Magro F; Cardoso H; Carneiro F; Portugal R; Lopes J; Costa Santos C
Inflamm Bowel Dis; 2008 May; 14(5):723-5. PubMed ID: 17929297
[No Abstract] [Full Text] [Related]
11. Drug-induced lupus erythematosus secondary to pirfenidone.
Kelly AS; De la Harpe Golden P; D'Arcy C; Lally A
Br J Dermatol; 2018 Jun; 178(6):1437-1438. PubMed ID: 29266198
[No Abstract] [Full Text] [Related]
12. Autoimmune hepatitis in two psoriasis patients treated with inflixmab.
Goujon C; Dahel K; Bérard F; Guillot I; Gunera-Saad N; Nicolas JF
J Am Acad Dermatol; 2010 Aug; 63(2):e43-4. PubMed ID: 20633783
[No Abstract] [Full Text] [Related]
13. Is the family history positive for SLE a predisposing factor for anti-TNFalpha blockers induced lupus? A case report.
Caramaschi P; Ravagnani V; Bambara LM; Biasi D
Joint Bone Spine; 2010 Oct; 77(5):484-5. PubMed ID: 20478734
[No Abstract] [Full Text] [Related]
14. Development of systemic lupus erythematosus in a patient with rheumatoid arthritis following treatment conversion of infliximab to adalimumab.
Havel J; Aboutalebi S; Doughty L; Wirges M
J Drugs Dermatol; 2008 Aug; 7(8):796-8. PubMed ID: 18720701
[TBL] [Abstract][Full Text] [Related]
15. [Infliximab-induced lupus erythematosus in a case of ulcerative colitis].
Nishikawa J; Miyazaki T; Suzuki N; Itaya Y; Yamawaki H; Mihara H; Hasumoto Y; Fujinami H; Ogawa K; Hosokawa A; Kudo T; Sugiyama T
Nihon Shokakibyo Gakkai Zasshi; 2011 Sep; 108(9):1535-9. PubMed ID: 21891993
[TBL] [Abstract][Full Text] [Related]
16. A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.
Menter A; Feldman SR; Weinstein GD; Papp K; Evans R; Guzzo C; Li S; Dooley LT; Arnold C; Gottlieb AB
J Am Acad Dermatol; 2007 Jan; 56(1):31.e1-15. PubMed ID: 17097378
[TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
De Bandt M; Sibilia J; Le Loët X; Prouzeau S; Fautrel B; Marcelli C; Boucquillard E; Siame JL; Mariette X;
Arthritis Res Ther; 2005; 7(3):R545-51. PubMed ID: 15899041
[TBL] [Abstract][Full Text] [Related]
18. Severe infliximab-induced psoriasis treated with adalimumab switching.
Faillace C; Duarte GV; Cunha RS; de Carvalho JF
Int J Dermatol; 2013 Feb; 52(2):234-8. PubMed ID: 22998330
[TBL] [Abstract][Full Text] [Related]
19. Pityriasis rosea-like arranged eruption after infliximab therapy in a patient with psoriasis vulgaris.
Ohtsuka T
J Dermatol; 2014 Apr; 41(4):354-5. PubMed ID: 24617533
[No Abstract] [Full Text] [Related]
20. Biological treatments for moderate-to-severe psoriasis: indirect comparison.
Galván-Banqueri M; Marín Gil R; Santos Ramos B; Bautista Paloma FJ
J Clin Pharm Ther; 2013 Apr; 38(2):121-30. PubMed ID: 23442134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
